Article Details

Biosense Webster Presents Late-Breaking Data From Inspire And Admire Clinical Trials ... - menafn

Retrieved on: 2024-02-03 13:38:15

Tags for this article:

Click the tags to see associated articles and topics

Biosense Webster Presents Late-Breaking Data From Inspire And Admire Clinical Trials ... - menafn. View article details on hiswai:

Summary

The article details successful outcomes of the VARIPULSETM Platform clinical trials by Biosense Webster Inc. for treating atrial fibrillation, highlighting an 80% success rate in preventing arrhythmia recurrence. The studies demonstrate the platform's efficacy and safety within global markets, with a focus on cardiology and electrophysiology.

Article found on: menafn.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up